Literature DB >> 1855279

Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil.

V Srimuninnimit1, G L Wampler.   

Abstract

We report on a rare case of malignant pheochromocytoma in a patient with a family history of this disease. After three cycles of treatment with cisplatin and 5-fluorouracil, a decrease in the need for antihypertensive treatment occurred, which lasted almost 2 years despite the discontinuation of chemotherapy. The patient showed an objective response, which was technically a minor response, although in this slow-growing tumor it was of major clinical significance. This chemotherapy regimen may play a role in the management of malignant pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855279     DOI: 10.1007/bf00685513

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

Review 1.  Pheochromocytoma.

Authors:  N A Samaan; R C Hickey
Journal:  Semin Oncol       Date:  1987-09       Impact factor: 4.929

2.  Treatment of malignant pheochromocytoma with combination chemotherapy.

Authors:  H R Keiser; D S Goldstein; J L Wade; F L Douglas; S D Averbuch
Journal:  Hypertension       Date:  1985 May-Jun       Impact factor: 10.190

3.  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

Authors:  B Shapiro; J E Copp; J C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

4.  Familial extra-adrenal pheochromocytoma. A new syndrome.

Authors:  J V Glowniak; B Shapiro; J C Sisson; N W Thompson; A G Coran; R Lloyd; R C Kelsch; W H Beierwaltes
Journal:  Arch Intern Med       Date:  1985-02

5.  Clinical experience with malignant pheochromocytomas.

Authors:  H W Scott; V Reynolds; N Green; D Page; J A Oates; D Robertson; S Roberts
Journal:  Surg Gynecol Obstet       Date:  1982-06

6.  Bone metastases in pheochromocytoma: comparative studies of efficacy of imaging.

Authors:  M D Lynn; E M Braunstein; R L Wahl; B Shapiro; M D Gross; R Rabbani
Journal:  Radiology       Date:  1986-09       Impact factor: 11.105

7.  Oncologic aspects of pheochromocytoma: the importance of follow-up.

Authors:  H W Scott; S A Halter
Journal:  Surgery       Date:  1984-12       Impact factor: 3.982

8.  Clinical study of pheochromocytoma.

Authors:  A G May; A Moss; O H Gutierrez; S Z Burday; R G Campbell
Journal:  Am J Surg       Date:  1981-03       Impact factor: 2.565

9.  Malignant phaeochromocytoma.

Authors:  H J Lewi; R Reid; B Mucci; J K Davidson; K F Kyle; S G Macpherson; P Semple; S Kaye
Journal:  Br J Urol       Date:  1985-08

10.  Pheochromocytoma: current status and changing trends.

Authors:  J A van Heerden; S G Sheps; B Hamberger; P F Sheedy; J G Poston; W H ReMine
Journal:  Surgery       Date:  1982-04       Impact factor: 3.982

View more
  4 in total

Review 1.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

Review 2.  Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.

Authors:  Camilo Jimenez; Eric Rohren; Mouhammed Amir Habra; Thereasa Rich; Paola Jimenez; Montserrat Ayala-Ramirez; Eric Baudin
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

Review 3.  Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas.

Authors:  G Eisenhofer; G Siegert; J Kotzerke; S R Bornstein; K Pacak
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

Review 4.  Treatment of malignant pheochromocytoma.

Authors:  R Adjallé; P F Plouin; K Pacak; H Lehnert
Journal:  Horm Metab Res       Date:  2009-08-11       Impact factor: 2.936

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.